ocrelizumab - CISMeF

Preferred Label : ocrelizumab;

MeSH note : a humanized anti-CD20 antibody;

CISMeF synonym : PR 070769; R 1594;

MeSH hyponym : R1594; R-1594; PR070769; PR-070769;

Is substance : O;

UNII : A10SJL62JY;

Details

Origin ID

C533411;

UMLS CUI

C1882138;

ATC code(s)
- ocrelizumab [ATC Code]
Currated CISMeF NLP mapping
- Ocrelizumab [SMS substance]
- Ocrelizumab [ICD-11 Extension code]
- Ocrelizumab [NCIt concept]
- Ocrelizumab (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- immunologic factors [MeSH Descriptor]
Record concept(s)
- Ocrevus [MeSH concept]
- PR 070769 [MeSH concept]
- R 1594 [MeSH concept]
- RG-1594 [MeSH concept]
- ocrelizumab [MeSH concept]
See also inter- (CISMeF)
- Product containing ocrelizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ocrelizumab [NCIt concept]
- Ocrelizumab (substance) [SNOMED CT concept]
- Product containing ocrelizumab (medicinal product) [SNOMED CT concept]
- ocrelizumab [ATC Code]
Validated automatic mappings to BTNT
- ocrelizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients